In a recent survey, KFF explored how people thought about long-term care, including the current care landscape, what programs cover long-term care, how individuals will pay for care if they need it, and whether those individuals have taken steps to prepare for any need. The survey shows that few adults […]
The growing enrollment in Medicare Advantage (MA) plans has raised concerns about the challenges beneficiaries who wish to switch between MA and Original Medicare face. Despite the increase in marketing tactics to sell people on MA plans, many MA enrollees feel buyers’ remorse and decide that that they prefer coverage […]
As we covered last month, authorization and funding for outreach and enrollment to low-income Medicare beneficiaries was dropped from the current short-term federal spending bill, or Continuing Resolution (CR), at the last minute. With work on the next CR underway, it’s critical that lawmakers hear from you today about this […]
Already in 2024, the Biden-Harris administration has finalized two important rules that will protect access to care and lessen hurdles for millions of people with Medicare, Medicaid, and Qualified Health Plans through the Affordable Care Act’s federal marketplaces. The first final rule—the conscience rule—rescinds the most damaging aspects of a […]
Yesterday, Medicare Rights joined nearly 30 national organizations representing Medicare beneficiaries, families, providers, employers, and advocates in urging Congress to address outdated Medicare policies that make routine services cost more based solely on where they are performed. These commonsense reforms would advance “site neutral” Medicare payments and improve billing transparency—paving […]
Last week, the Medicare Rights Center submitted comments on a proposed rule that would increase awareness of and access to Medicare Advantage (MA) supplemental benefits, make the connections between Medicare and Medicaid stronger for those who are dually eligible for both programs, require evaluations of plan prior authorization patterns, and […]
A newly effective Inflation Reduction Act (IRA) provision is improving prescription drug affordability for many people with Medicare Part D — but too few know about it, potentially limiting its efficacy. As of January 1, 2024, Part D enrollees are no longer required to pay 5% coinsurance after they reach […]
Last month, the office of the Assistant Secretary for Planning and Evaluation (ASPE), a research arm of the Department of Health and Human Services (HHS), released a report on the background, use, and costs of the 10 drugs selected for the first-ever Medicare price negotiation process. The medications were chosen […]
